Intralesional rhEGF is a well-established therapeutic agent with a solid foundation of more than three decades of research and development. This research has been conducted extensively both in Cuba and on the international stage, affirming its significance in the medical field.
The robust pedigree of intralesional rhEGF continues to expand through ongoing contributions to scientific publications.
Copyright © 2024 DISCOVERY THERAPEUTICS CARIBE - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.